Bioxytran, Inc. (OTCMKTS:BIXT) Short Interest Update

Bioxytran, Inc. (OTCMKTS:BIXT) was the recipient of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 100 shares, a drop of 99.1% from the September 30th total of 11,600 shares. Based on an average daily volume of 89,700 shares, the days-to-cover ratio is currently 0.0 days.

Bioxytran Stock Performance

OTCMKTS:BIXT opened at $0.09 on Friday. The stock has a 50 day moving average price of $0.10 and a 200 day moving average price of $0.11. The stock has a market cap of $16.34 million, a PE ratio of -3.07 and a beta of -0.89. Bioxytran has a one year low of $0.07 and a one year high of $0.18.

Bioxytran Company Profile

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company’s lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.